The Valley Desk

NCT02797080 · Interventional trial

Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia

Overall registry status Completed

Phase 3

Conditions Friedreich's Ataxia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov